News
The most up to date reporting and breakthroughs in anal cancer and HPV research, and Anal Cancer Foundation’s latest activities and events.
Foundation Featured in The New York Times
In February 2011, the Almada family appeared in The New York Times explaining why they set up The Anal Cancer. Read the full article here
A New Year (and a Slightly New Name)
Welcome to the New Year! We are looking forward to 2011’s potential for healing, building our organization and expanding knowledge and resources for anal cancer in the general public and medical community. We are proud of what we have accomplished since our mother, Paulette, died on April 5th, 2010. That is, in no small part,… read more
FDA Expands Gardasil Vaccine Indication to Include Anal Cancer
The Federal Drug Administration (FDA) announced yesterday their decision to expand the use of the human papillomavirus (HPV) vaccine, Gardasil, to prevent anal cancer and precancerous lesions. The Anal Cancer Foundation (the Foundation) testified in November before the FDA to urge the agency to approve Gardasil for the prevention of anal cancer in males and… read more
Foundation Attends Partnering for Cures
On December 14th and 15th, co-Founders Justine, Tristan and Camille Almada attended the FasterCures “Partnering for Cures” conference at the Grand Hyatt in New York, NY. FasterCures is a non-profit think tank created by Michael Milken, the financier and philanthropist, who founded the Prostate Cancer Foundation, various education and economic initiatives, and recently enrolled in… read more
In Honor of Randy
We write in memory of Randy Allgaier, who died on Saturday, November 27th, 2010 after complications from treatment for anal cancer. We honor him for fiercely advocating healthcare equality for stigmatized diseases and sharing the anal cancer experience openly. For over two decades, Mr. Allgaier fought for equal rights, treatment and health options for the… read more
Calling on FDA to Approve HPV Vaccine to Prevent Anal Cancer
The Anal Cancer Foundation Calls on FDA to Approve HPV Vaccine Gardasil to Prevent Anal Cancer in Men and Women The Anal Cancer Foundation (the “Foundation”) testified November 17, 2010 before the Federal Drug Administration (FDA) Advisory Committee on Vaccines and Related Biological Products to urge the agency to approve the human papillomavirus (HPV) vaccine,… read more
In Honor of Mom
One of the greatest challenges of starting a health organization for an orphan disease that few are comfortable talking about – anal cancer, and its primary cause, HPV – is deciding where to begin. It’s especially hard when people don’t even know what the disease is. When our mother, Paulette Crowther, passed away on April… read more
Thrive On!
We just returned from California, which is the only place in the world that’s having a worse summer than England. We met with thrivers (anal cancer patients) in Los Angeles and San Francisco. It felt so good to see the smiles on their faces when we told them what we are up to. We are… read more
HPV 2010 Conference Summary
The HPV2010 conference we just attended in Montreal, Canada, was a huge success. Every year researchers, clinicians, and government representatives gather from around the world to attend this HPV conference. Visitors share their latest findings, participate in workshops and meet others studying and working on the Papillomavirus. There was a good buzz regarding progress in… read more
